Vascular/Lymphatic Malformation: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
{{Stub Notice}} | {{Stub Notice}} | ||
Bleomycin | <b>Bleomycin</b> | ||
[https://pubmed.ncbi.nlm.nih.gov/88070/ The hazards of anesthesia and surgery in bleomycin-treated patients] | [https://pubmed.ncbi.nlm.nih.gov/88070/ The hazards of anesthesia and surgery in bleomycin-treated patients] | ||
[https://www.jvir.org/article/S1051-0443(18)31591-4/fulltext Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations] | [https://www.jvir.org/article/S1051-0443(18)31591-4/fulltext Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations] | ||
Revision as of 13:58, 27 April 2023
This is a Stub Notice. This page has not been completed. You can work on this page by signing in and going to the Edit tab. Thanks for helping to make PedsAnesthesia.Net Wiki useful.
Go to the Main Page to see the Topic Outline.
Go to the Generalized Suggested Outline for information on case-specific details for each page.
Go to the Test Page for examples on how to use references in the page.
Relevant Article Depot:
Bleomycin
The hazards of anesthesia and surgery in bleomycin-treated patients
Hyperpigmentation after Foamed Bleomycin Sclerotherapy for Vascular Malformations